BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 25402849)

  • 1. Protein prenylation: enzymes, therapeutics, and biotechnology applications.
    Palsuledesai CC; Distefano MD
    ACS Chem Biol; 2015 Jan; 10(1):51-62. PubMed ID: 25402849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using inhibitors of prenylation to block localization and transforming activity.
    Berzat AC; Brady DC; Fiordalisi JJ; Cox AD
    Methods Enzymol; 2006; 407():575-97. PubMed ID: 16757354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein Prenyltransferases and Their Inhibitors: Structural and Functional Characterization.
    Marchwicka A; Kamińska D; Monirialamdari M; Błażewska KM; Gendaszewska-Darmach E
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the biochemistry of the prenylome and its role in disease through proteomics: progress and potential.
    Brioschi M; Martinez Fernandez A; Banfi C
    Expert Rev Proteomics; 2017 Jun; 14(6):515-528. PubMed ID: 28521569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoprenoids and protein prenylation: implications in the pathogenesis and therapeutic intervention of Alzheimer's disease.
    Jeong A; Suazo KF; Wood WG; Distefano MD; Li L
    Crit Rev Biochem Mol Biol; 2018 Jun; 53(3):279-310. PubMed ID: 29718780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein prenyltransferases: anchor size, pseudogenes and parasites.
    Maurer-Stroh S; Washietl S; Eisenhaber F
    Biol Chem; 2003 Jul; 384(7):977-89. PubMed ID: 12956414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models.
    Lobell RB; Omer CA; Abrams MT; Bhimnathwala HG; Brucker MJ; Buser CA; Davide JP; deSolms SJ; Dinsmore CJ; Ellis-Hutchings MS; Kral AM; Liu D; Lumma WC; Machotka SV; Rands E; Williams TM; Graham SL; Hartman GD; Oliff AI; Heimbrook DC; Kohl NE
    Cancer Res; 2001 Dec; 61(24):8758-68. PubMed ID: 11751396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caged protein prenyltransferase substrates: tools for understanding protein prenylation.
    DeGraw AJ; Hast MA; Xu J; Mullen D; Beese LS; Barany G; Distefano MD
    Chem Biol Drug Des; 2008 Sep; 72(3):171-81. PubMed ID: 18844669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure, catalysis, and inhibition mechanism of prenyltransferase.
    Chang HY; Cheng TH; Wang AH
    IUBMB Life; 2021 Jan; 73(1):40-63. PubMed ID: 33246356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel prenyltransferase enzymes as a tool for flavonoid prenylation.
    Botta B; Delle Monache G; Menendez P; Boffi A
    Trends Pharmacol Sci; 2005 Dec; 26(12):606-8. PubMed ID: 16229901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Advances in the Development of Mammalian Geranylgeranyl Diphosphate Synthase Inhibitors.
    Haney SL; Wills VS; Wiemer DF; Holstein SA
    Molecules; 2017 May; 22(6):. PubMed ID: 28555000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of synthetic isoprenoid analogues for understanding protein prenyltransferase mechanism and structure.
    Kale TA; Hsieh SA; Rose MW; Distefano MD
    Curr Top Med Chem; 2003; 3(10):1043-74. PubMed ID: 12769708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein prenylation: unique fats make their mark on biology.
    Wang M; Casey PJ
    Nat Rev Mol Cell Biol; 2016 Feb; 17(2):110-22. PubMed ID: 26790532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of prenylation of Ras and other G-proteins and their application as therapeutics.
    Cohen LH; Pieterman E; van Leeuwen RE; Overhand M; Burm BE; van der Marel GA; van Boom JH
    Biochem Pharmacol; 2000 Oct; 60(8):1061-8. PubMed ID: 11007942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and specificity profiling of protein prenyltransferase inhibitors using new fluorescent phosphoisoprenoids.
    Dursina B; Reents R; Delon C; Wu Y; Kulharia M; Thutewohl M; Veligodsky A; Kalinin A; Evstifeev V; Ciobanu D; Szedlacsek SE; Waldmann H; Goody RS; Alexandrov K
    J Am Chem Soc; 2006 Mar; 128(9):2822-35. PubMed ID: 16506760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational design of Ras prenyltransferase inhibitors as potential anticancer drugs.
    Sebti SM; Hamilton AD
    Biochem Soc Trans; 1996 Aug; 24(3):692-9. PubMed ID: 8878828
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of Ras prenylation: a signaling target for novel anti-cancer drug design.
    Lerner EC; Hamilton AD; Sebti SM
    Anticancer Drug Des; 1997 Jun; 12(4):229-38. PubMed ID: 9199657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diversity of ABBA Prenyltransferases in Marine Streptomyces sp. CNQ-509: Promiscuous Enzymes for the Biosynthesis of Mixed Terpenoid Compounds.
    Leipoldt F; Zeyhle P; Kulik A; Kalinowski J; Heide L; Kaysser L
    PLoS One; 2015; 10(12):e0143237. PubMed ID: 26659564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein prenylation in eukaryotic microorganisms: genetics, biology and biochemistry.
    Omer CA; Gibbs JB
    Mol Microbiol; 1994 Jan; 11(2):219-25. PubMed ID: 8170384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of inhibitors of protein farnesylation as potential chemotherapeutic agents.
    Kohl NE; Conner MW; Gibbs JB; Graham SL; Hartman GD; Oliff A
    J Cell Biochem Suppl; 1995; 22():145-50. PubMed ID: 8538192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.